Lotemax

Company: Bausch & Lomb, Pharmos
Approval Status: Approved March 1998
Treatment for: post-operative eye inflammation
Areas: Eye Health / Ophthalmology

| General Information |

General Information

Lotemax is a topical, site-specific steroid that will be used to treat post-operative eye inflammation such as that experienced following cataract surgery. The new prescription eye drop will also be used for various other inflammatory eye conditions.

< back to top

Lotemax Drug Information

The Lotemax drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.